Form D · Other
Watchmaker Genomics, Inc.
Boulder, CO · CIK 0001819587
Offering snapshot reported Jun 3, 2022 · SEC filing
- Reported sold
- $40M Offering amount: $40M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 3, 2022 | Initial | $40,000,000 | No comparison | 2 | SEC filing |
| Dec 4, 2020 | Amendment | $8,272,983 | $1,599,997vs Aug 27, 2020 | 27 | SEC filing |
| Aug 27, 2020 | Initial | $6,672,986 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448101
Source: Form D, filed Jun 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Deneau | Executive |
| John Foskett | Director, Executive, Promoter |
| Brian Kudlow | Director, Executive, Promoter |
| Paul Mc Ewan | Director, Promoter |
| Christopher Mc Guinness | Director |
| Stephen Picone | Director, Executive, Promoter |
| Victor Tong | Director |
Issuer details
Industry: Other (See others in industry)
Address:
5744 Central Ave, Suite 100
Boulder, CO, 80301
Boulder, CO, 80301